Clinical Trial Update: VZV Vaccine for Hematopoietic Stem Cell Transplantation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update for a Varicella Zoster vaccine used in hematopoietic stem cell transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella-zoster Infection

Drugs mentioned

• VZV Vaccine for Hematopoietic Stem Cell Transplantation

Snippet

Sponsor: The University of Hong Kong | Conditions: Varicella Zoster Infection | Phase 2, Phase 3 | Status: COMPLETED